Results 311 to 320 of about 690,479 (320)
Some of the next articles are maybe not open access.
Clinics in Liver Disease, 2006
The number of patients who have hepatocellular carcinoma (HCC) is expected to more than double over the next 1 to 2 decades. Patients who have cirrhosis, regardless of cause, are at the highest risk for developing HCC. This article discusses surveillance of these patients for HCC by alpha-fetoprotein and ultrasound, evaluation using imaging ...
Jorge A, Marrero, Shawn, Pelletier
openaire +2 more sources
The number of patients who have hepatocellular carcinoma (HCC) is expected to more than double over the next 1 to 2 decades. Patients who have cirrhosis, regardless of cause, are at the highest risk for developing HCC. This article discusses surveillance of these patients for HCC by alpha-fetoprotein and ultrasound, evaluation using imaging ...
Jorge A, Marrero, Shawn, Pelletier
openaire +2 more sources
The Lancet, 2018
Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function.
Alejandro, Forner +2 more
openaire +2 more sources
Hepatocellular carcinoma appears frequently in patients with cirrhosis. Surveillance by biannual ultrasound is recommended for such patients because it allows diagnosis at an early stage, when effective therapies are feasible. The best candidates for resection are patients with a solitary tumour and preserved liver function.
Alejandro, Forner +2 more
openaire +2 more sources
New England Journal of Medicine, 2019
Silvestre R, Duran, Robert D B, Jaquiss
openaire +6 more sources
Silvestre R, Duran, Robert D B, Jaquiss
openaire +6 more sources
Screening for hepatocellular carcinoma
Hepatology Research, 1999This article reviews methodological issues around screening for hepatocellular carcinoma, and discusses selection of the at‐risk group, which screening test to use, and how frequently it should be applied. Screening of patients at risk for hepatocellular carcinoma should be undertaken using ultrasonography applied at six‐month intervals.
openaire +6 more sources